Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Alembic Pharma gets USFDA okay for Sumatriptan Injection, Single Dose Autoinjector System

Ruchika Sharma8 Nov 2025 11:44 AM IST

Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) for its...

Zydus Lifesciences bags tentative USFDA nod for cancer drug Olaparib

Ruchika Sharma7 Nov 2025 6:23 PM IST

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) for Olaparib ...

GSK pulmonary neuroendocrine carcinoma treatment gets Orphan Drug Designation in EU

GSK Pharma net profit rises 2 percent to Rs 255 crore in Q2

Ruchika Sharma7 Nov 2025 6:06 PM IST

GlaxoSmithKline Pharmaceuticals has recorded a 2 percent year-on-year rise in net profit to Rs 255 crore for the quarter ended September 30, 2025.The...

Senores Pharma: Manohar Lalge, President- RnD, categorised as Senior Management Personnel

Ruchika Sharma7 Nov 2025 4:21 PM IST

Ahmedabad: Senores Pharma has announced the appointment and categorization of Manohar Lalge, President-Research and Development, as Senior...

USFDA concludes inspection with no 483 observations at Divis Labs Telangana facility

Divi's Labs elevates Nimmagadda Venkata Anirudh as President (Nutraceuticals)

Ruchika Sharma7 Nov 2025 3:36 PM IST

Telangana: Divi's Labs has elevated Nimmagadda Venkata Anirudh as President (Nutraceuticals) and Senior Management Personnel.He will be...

Alembic Pharma gets USFDA nod for angina drug Diltiazem Hydrochloride

Alembic Pharma bags USFDA nod for blood cancer drug Dasatinib

Ruchika Sharma7 Nov 2025 2:54 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration...

Alembic Pharma converts UAE branch office into wholly owned subsidiary

Ruchika Sharma7 Nov 2025 11:30 AM IST

Vadodara: Alembic Pharma has announced that the Company's Branch office in the United Arab Emirates has been converted into a Wholly Owned Subsidiary...

No Trial Waiver: CDSCO Panel Directs Sun Pharma to Run Phase III Study for Somatropin Liquid Injection Citing Lack of India-Specific Data

Sun Pharma open to enhance manufacturing footprint in US

Ruchika Sharma6 Nov 2025 5:15 PM IST

New Delhi: Sun Pharma has kept its options open on enhancing its manufacturing footprint in the U.S., even as the U.S. administration's 100%...

Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in Chile

Q2 results: Aurobindo Pharma net profit rises 4 percent to Rs 848 crore

Ruchika Sharma6 Nov 2025 3:06 PM IST

New Delhi: Hyderabad-based pharmaceutical giant Aurobindo Pharma Limited has reported a 4 percent jumpin consolidated net profit to Rs 848 crore...

USFDA concludes inspection at Marksans Pharma Goa facility with zero Form 483 observation

Senores Pharma arm facility gets USFDA EIR

Ruchika Sharma6 Nov 2025 1:55 PM IST

Senores Pharma has announced that the United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for...

Sun Pharma Wins Rs 828 Crore Excise Refund Battle, CESTAT Rules Revenue Demand Legally Unsustainable

Sun Pharma net profit up 3 percent at Rs 3118 crore in Q2

Ruchika Sharma6 Nov 2025 1:00 PM IST

New Delhi: Pharma leader Sun Pharmaceutical Industries has recorded a Rs 3,118 crore net profit in Q2 FY26, up 2.56 percent, as India and...

Zydus Amplitude receives CE mark for robotic surgical system Andy

Zydus gets USFDA Orphan Drug Designation for Desidustat for beta-thalassemia

Ruchika Sharma6 Nov 2025 12:00 PM IST

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that the United States Food and Drug Administration (USFDA) has...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok